FR3061178B1 - Peptides antimicrobiens et leurs utilisations - Google Patents
Peptides antimicrobiens et leurs utilisations Download PDFInfo
- Publication number
- FR3061178B1 FR3061178B1 FR1663231A FR1663231A FR3061178B1 FR 3061178 B1 FR3061178 B1 FR 3061178B1 FR 1663231 A FR1663231 A FR 1663231A FR 1663231 A FR1663231 A FR 1663231A FR 3061178 B1 FR3061178 B1 FR 3061178B1
- Authority
- FR
- France
- Prior art keywords
- antimicrobial peptides
- peptides
- inflammatory diseases
- antimicrobial
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1663231A FR3061178B1 (fr) | 2016-12-22 | 2016-12-22 | Peptides antimicrobiens et leurs utilisations |
EP17838052.3A EP3559025A1 (fr) | 2016-12-22 | 2017-12-22 | Peptides antimicrobiens et leurs utilisations |
MX2019007390A MX2019007390A (es) | 2016-12-22 | 2017-12-22 | Peptidos antimicrobianos y usos de los mismos. |
US16/472,447 US20230192772A1 (en) | 2016-12-22 | 2017-12-22 | Antimicrobial peptides and uses thereof |
PCT/FR2017/053835 WO2018115798A1 (fr) | 2016-12-22 | 2017-12-22 | Peptides antimicrobiens et leurs utilisations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1663231A FR3061178B1 (fr) | 2016-12-22 | 2016-12-22 | Peptides antimicrobiens et leurs utilisations |
FR1663231 | 2016-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3061178A1 FR3061178A1 (fr) | 2018-06-29 |
FR3061178B1 true FR3061178B1 (fr) | 2021-02-12 |
Family
ID=58645166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1663231A Expired - Fee Related FR3061178B1 (fr) | 2016-12-22 | 2016-12-22 | Peptides antimicrobiens et leurs utilisations |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230192772A1 (fr) |
EP (1) | EP3559025A1 (fr) |
FR (1) | FR3061178B1 (fr) |
MX (1) | MX2019007390A (fr) |
WO (1) | WO2018115798A1 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1163352A1 (fr) * | 1999-03-17 | 2001-12-19 | University Of Victoria Innovation And Development Corporation | Plantes transgeniques resistant a une large variete de pathogenes |
US20100004166A1 (en) * | 2006-03-23 | 2010-01-07 | Richard Pittner | Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic Diseases |
FR2947455B1 (fr) * | 2009-07-01 | 2014-01-03 | Centre Nat Rech Scient | La dermaseptine b2 comme inhibiteur de la croissance tumorale |
EP3384938A1 (fr) * | 2011-09-12 | 2018-10-10 | Moderna Therapeutics, Inc. | Acides nucléiques techniques et leurs procédés d'utilisation |
-
2016
- 2016-12-22 FR FR1663231A patent/FR3061178B1/fr not_active Expired - Fee Related
-
2017
- 2017-12-22 US US16/472,447 patent/US20230192772A1/en not_active Abandoned
- 2017-12-22 MX MX2019007390A patent/MX2019007390A/es unknown
- 2017-12-22 EP EP17838052.3A patent/EP3559025A1/fr not_active Withdrawn
- 2017-12-22 WO PCT/FR2017/053835 patent/WO2018115798A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
MX2019007390A (es) | 2019-12-05 |
FR3061178A1 (fr) | 2018-06-29 |
EP3559025A1 (fr) | 2019-10-30 |
WO2018115798A1 (fr) | 2018-06-28 |
US20230192772A1 (en) | 2023-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA53937A (fr) | Compositions comprenant des souches bactériennes | |
MA41013B1 (fr) | Compositions comprenant des souches bactériennes | |
MA47119B1 (fr) | Administration de protéine à base de bactéries à virulence atténuée | |
MA47313B1 (fr) | Formulations sous-cutanées d'anticorps her2 | |
MA39094A1 (fr) | Polythérapie comprenant un inhibiteur de mdm2 et un ou plusieurs principes pharmaceutiquement actifs supplémentaires pour le traitement de cancers | |
BR112016030541A2 (pt) | métodos para o tratamento de infecções fúngicas | |
CY1123189T1 (el) | Αντιμικροβiακο πεπτιδιο | |
MA34002B1 (fr) | Thérapie antivirale | |
UY37789A (es) | Nuevos derivados de azaquinolina | |
BR112016019592A8 (pt) | Composto, uso de um composto, e, composição farmacêutica | |
MA45172B1 (fr) | Arn modifié codant pour des polypeptides vegf-a, formulations et utilisations associées | |
MA43113B1 (fr) | Anticorps anti-htr a1 et méthodes d'utilisation de ceux-ci | |
BR112018013084A2 (pt) | tratamentos de combinação compreendendo a administração de imidazopirazinonas | |
EA202190510A1 (ru) | Новое лекарственное средство для лечения воспалительной болезни кишечника | |
FR3063645B1 (fr) | Acefapc pour le traitement des maladies acetylcholine dependantes | |
MA38369B1 (fr) | Peptides et compositions pour le traitement d'une lesion de l'articulation | |
MA39447B1 (fr) | Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
MA54936A (fr) | Triamtérène ou nolatrexed destinés à être utilisés dans le traitement de la phénylcétonurie | |
MA42455B1 (fr) | Nouveau composé hétérocyclique, procédé de préparation associé et composition pharmaceutique le comprenant | |
EA202091308A1 (ru) | Модифицированный вакцинный штамм brucella для лечения бруцеллеза | |
FR3081325B1 (fr) | Diltiazem pour son utilisation dans le traitement des infections microbiennes | |
MA39448B1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
FR3061178B1 (fr) | Peptides antimicrobiens et leurs utilisations | |
BR112022000417A2 (pt) | Proteínas de toxina de fusão para tratamento de doenças relacionadas a infecções por cmv | |
MA40844A (fr) | Compositions pharmaceutiques à action prolongée pour l'hépatite c |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20180629 |
|
TQ | Partial transmission of property |
Owner name: SORBONNE UNIVERSITE, FR Effective date: 20180704 Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA, FR Effective date: 20180704 Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR Effective date: 20180704 Owner name: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO, MX Effective date: 20180704 Owner name: UNIVERSITE PARIS-SUD 11, FR Effective date: 20180704 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
TQ | Partial transmission of property |
Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA, FR Effective date: 20201204 Owner name: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO, MX Effective date: 20201204 Owner name: SORBONNE UNIVERSITE, FR Effective date: 20201204 Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR Effective date: 20201204 Owner name: UNIVERSITE PARIS-SACLAY, FR Effective date: 20201204 |
|
CA | Change of address |
Effective date: 20210913 |
|
ST | Notification of lapse |
Effective date: 20220808 |